Vialwirebiotech, curated
September 30, 2026, 3:44 PM
September 26, 2026
- 12:00 AM · FT — Pharmaceuticals12:00 AMMedicines run short in Iran under US sanctions — FT — Pharmaceuticals
September 25, 2026
- 9:00 PM · SCMP — Tech
- 6:00 PM · Nikkei Asia6:00 PMJapan herbal remedy makers seek to reduce China from supply chain — Nikkei Asia
- 1:50 PM · STAT News
- 1:00 PM · FT — Pharmaceuticals1:00 PMDirectors’ Deals: AstraZeneca’s Soriot in a major show of faith — FT — Pharmaceuticals
- 12:00 PM · BioWorld12:00 PMNanexa’s $1.3B drug delivery deal offers Novo longer-acting peptides — BioWorld
- 12:00 PM · BioWorld12:00 PMAcadia push in ADP still alive after near miss in phase II — BioWorld
- 12:00 PM · BioWorld12:00 PMJury awards $90M to Nektar in Lilly dispute over rezpeg — BioWorld
- 12:00 PM · BioWorld12:00 PMRemynd raises €3.5M to get novel Alzheimer’s program back on track — BioWorld
- 11:25 AM · STAT News11:25 AMSTAT+: Lilly wins approval for once-weekly insulin shot — STAT News
- 9:51 AM · Pharmaceutical Technology9:51 AMAptar Pharma and Macquarie University partner on drug delivery project — Pharmaceutical Technology
- 9:50 AM · Pharmaceutical Executive9:50 AM<![CDATA[FDA Approves Welireg Plus Lenvima for Previously Treated Adult Patients With ccRCC]]> — Pharmaceutical Executive
- 9:00 AM · BioWorld9:00 AMXtalpi submits IND for KQTD-126 for chronic intestinal pain — BioWorld
- 9:00 AM · BioWorld9:00 AMBristol Myers Squibb patents new NIK inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMPrime Medicine’s PM-647 gains IND approval for AATD — BioWorld
- 9:00 AM · BioWorld9:00 AMAptevo advances APVO-451 toward IND-enabling studies — BioWorld
- 9:00 AM · BioWorld9:00 AMSaniona eyes IND submission for SAN-2465 — BioWorld
- 9:00 AM · BioWorld9:00 AMSotio’s SOT-106 designated orphan drug for soft tissue sarcoma — BioWorld
- 6:47 AM · Drug Discovery World6:47 AMEC approves first treatment for rare neurodegenerative disease — Drug Discovery World
- 6:30 AM · SCMP — Tech6:30 AMChina and EU deadlocked on medical devices, still talking on PHEV curbs: source — SCMP — Tech
- 5:10 AM · Pharmaceutical Technology5:10 AMAmberstone and Henlius agree to develop solid-tumour T-cell engagers — Pharmaceutical Technology
- 5:09 AM · Drug Discovery World5:09 AMOna Therapeutics moves to Phase I with ADC for advanced cancers — Drug Discovery World
- 4:00 AM · Labiotech (EU)4:00 AMTheialife’s race to bring a childhood myopia treatment to market — Labiotech (EU)
- 2:50 AM · BBC — Health2:50 AMHow a rapid new test is helping brain tumour patients — BBC — Health
- 12:00 AM · FT — Pharmaceuticals12:00 AMPharma deal fever boosts flurry of highly complex mergers — FT — Pharmaceuticals
September 24, 2026
- 8:36 PM · BioPharma Dive8:36 PMRNAi drug specialist ADARx raises $446M IPO — BioPharma Dive
- 5:08 PM · BioPharma Dive5:08 PMGrail multicancer detection test wins FDA advisers’ backing — BioPharma Dive
- 4:46 PM · BioPharma Dive4:46 PMFDA nominee Overton parries vaccine questions at Senate hearing — BioPharma Dive